Clinical trial
Dexamethasone Therapy in VLBW Infants at Risk of CLD
NCT00011362 · NICHD Neonatal Research Network, Other · Completed
Key facts
| NCT number | NCT00011362 |
|---|---|
| Title | Dexamethasone Therapy in VLBW Infants at Risk of CLD |
| Official title | Randomized Clinical Trial of Dexamethasone Therapy in Very-Low-Birth-Weight Infants at Risk for Chronic Lung Disease (CLD) |
| Acronym | Dexamethasone |
| Lead sponsor | NICHD Neonatal Research Network, Other |
| Collaborators | National Center for Research Resources (NCRR) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infant, Newborn, Low Birth Weight, Small for Gestational Age, Premature, Bronchopulmonary Dysplasia |
| Intervention type | Drug |
| Interventions | Dexamethasone Early, Dexamethasone Late |
| Enrollment | 371 |
| Start date | Sep 1, 1992 |
| Primary completion | Jan 1, 1994 |
| Completion | Apr 1, 1994 |
| First posted | Feb 19, 2001 |
| Last update posted | Mar 22, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: